TAXONOMY PATHWAYS

taXonomy Pathways combines closed claims with labs, EHR, including clinician notes, to deliver a comprehensive view of inflammatory bowel disease. The ulcerative colitis cohort features:

• 
  Closed claims: 1.3 M patients
• 
  Pharmacy claims: 1.2 M patients (≈ 90 %)
• 
  EHR data: 0.6 M patients (≈ 48 %) with severity scores and endoscopy notes
• 
  Lab data: 1.0 M patients (≈ 79 %) including CRP, ESR and stool calprotectin

Fill out the form to schedule a meeting and explore our ulcerative colitis dataset.